On June 11, 2026, Fortune Enrichment Holdings Ltd (identified in the filing as WBT Value Limited) filed a Schedule 13G reporting a significant new ownership stake in Canada Goose Holdings Inc. (GOOS). The reporting persons, which include WBT Value Limited, Lucky Season Limited, Lucky Season Trust, and beneficiary Zheyu...

On June 11, 2026, Iroquois Capital Management, LLC, along with Richard Abbe and Kimberly Page, filed a Schedule 13G regarding their holdings in XWELL, Inc. (XWEL). The filing reveals that Iroquois Capital Management, LLC beneficially owns 354,467 shares of Common Stock, representing a 4.2% stake in the company. These s...

On June 11, 2026, reporting persons Sandie Gong and Devon Xu filed a Schedule 13G disclosing a 12.3% ownership stake in Aditxt, Inc. (ADTX). The filing reports the beneficial ownership of 100,000 shares of Common Stock as of the event date of June 9, 2026. The shares were held in a brokerage account in the name of Sand...

On June 11, 2026, TCG Crossover GP II, LLC and associated entities, including Chen Yu, filed a Schedule 13G regarding their holdings in Zai Lab Limited (ZLAB). The filing reveals that the reporting persons collectively hold 59,130,750 Ordinary Shares, representing a 5.3% ownership stake in the company. Specifically, TC...

On June 10, 2026, AB Value Partners, LP, alongside AB Value Management LLC and Andrew Berger, filed a Schedule 13G disclosing a new 7.1% stake in FONAR Corporation (FONR). The reporting group collectively beneficially owns 439,318 shares of Common Stock. This initial filing follows an event date of June 1, 2026, markin...

Alon Abady, appearing as a reporting person alongside Moniqua 30 LLC and two trusts, filed a Schedule 13G regarding Patriot National Bancorp Inc. The filing reports a beneficial ownership of 19,700,000 shares, representing 9.99% of the company's common stock. This ownership position is subject to a 9.99% blocker limita...

On June 10, 2026, Merus Global Investments, LLC filed a Schedule 13G with the SEC, reporting a new ownership stake in D. Boral ARC Acquisition I Corp. (BCAR). As of the event date on June 8, 2026, the filer reported holding 1,458,618 Class A ordinary shares, representing 5.1% of the company's outstanding shares. This f...

On June 10, 2026, AB Value Partners, LP, alongside AB Value Management LLC and Andrew Berger, filed a Schedule 13G disclosing a new 7.1% stake in FONAR Corporation (FONR). The reporting group collectively beneficially owns 439,318 shares of Common Stock. This initial filing follows an event date of June 1, 2026, markin...

On June 10, 2026, Tang Capital Management, LLC, led by Kevin Tang, filed a Schedule 13G indicating a new substantial position in Fulcrum Therapeutics, Inc. (FULC). As of the event date on June 3, 2026, the reporting group collectively beneficially owns 5,451,800 shares of common stock, representing 8.2% of the company'...

On June 10, 2026, Glazer Capital, LLC and its Managing Member, Paul J. Glazer, filed a Schedule 13G regarding their holdings in KalVista Pharmaceuticals, Inc. (KALV). The filing indicates that as of the event date on June 3, 2026, the reporting persons beneficially owned 2,581,700 shares of common stock, representing a...

James C. Jones (the Reporting Person) filed a Schedule 13G on June 10, 2026, reporting a new significant ownership stake in Global Innovative Platforms Inc. (GIPL). According to the filing, the event triggering this requirement occurred on March 31, 2021, when Mr. Jones acquired 92,812 shares of Common Stock from David...

On June 10, 2026, Integrated Core Strategies (US) LLC, along with Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, filed a Schedule 13G reporting a new 7.2% stake in Quince Therapeutics, Inc. (QNCX). The reporting group collectively beneficially owns 1,403,580 shares of Common Stock....

James C. Jones (the Reporting Person) filed a Schedule 13G on June 10, 2026, reporting a new significant ownership stake in Global Innovative Platforms Inc. (GIPL). According to the filing, the event triggering this requirement occurred on March 31, 2021, when Mr. Jones acquired 92,812 shares of Common Stock from David...

On June 10, 2026, Glazer Capital, LLC and its Managing Member, Paul J. Glazer, filed a Schedule 13G regarding their holdings in KalVista Pharmaceuticals, Inc. (KALV). The filing indicates that as of the event date on June 3, 2026, the reporting persons beneficially owned 2,581,700 shares of common stock, representing a...

On June 10, 2026, Merus Global Investments, LLC filed a Schedule 13G with the SEC, reporting a new ownership stake in D. Boral ARC Acquisition I Corp. (BCAR). As of the event date on June 8, 2026, the filer reported holding 1,458,618 Class A ordinary shares, representing 5.1% of the company's outstanding shares. This f...

Alon Abady, appearing as a reporting person alongside Moniqua 30 LLC and two trusts, filed a Schedule 13G regarding Patriot National Bancorp Inc. The filing reports a beneficial ownership of 19,700,000 shares, representing 9.99% of the company's common stock. This ownership position is subject to a 9.99% blocker limita...

On June 10, 2026, Portolan Capital Management, LLC, and its manager George McCabe, filed a Schedule 13G with the SEC, reporting a significant increase in their stake in Tecogen Inc. (TGEN). As of the event date on June 3, 2026, the reporting persons beneficially own 1,552,232 shares of common stock, representing a 5.19...

On June 10, 2026, Integrated Core Strategies (US) LLC, along with Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander, filed a Schedule 13G reporting a new 7.2% stake in Quince Therapeutics, Inc. (QNCX). The reporting group collectively beneficially owns 1,403,580 shares of Common Stock....

On June 10, 2026, Tang Capital Management, LLC, led by Kevin Tang, filed a Schedule 13G indicating a new substantial position in Fulcrum Therapeutics, Inc. (FULC). As of the event date on June 3, 2026, the reporting group collectively beneficially owns 5,451,800 shares of common stock, representing 8.2% of the company'...

On June 10, 2026, Portolan Capital Management, LLC, and its manager George McCabe, filed a Schedule 13G with the SEC, reporting a significant increase in their stake in Tecogen Inc. (TGEN). As of the event date on June 3, 2026, the reporting persons beneficially own 1,552,232 shares of common stock, representing a 5.19...

Jane Street Group, LLC has filed a Schedule 13G to report a new passive ownership stake in Bitdeer Technologies Group (BTDR). As of the event date on June 3, 2026, Jane Street Group, LLC, along with its subsidiaries Jane Street Capital, LLC and Jane Street Global Trading, LLC, beneficially owns 10,220,761 Class A ordin...

On June 9, 2026, Context Capital Management, LLC, along with affiliated entities and individuals, filed a Schedule 13G disclosing a new 9.9% stake in Gossamer Bio, Inc. (GOSS). The reporting persons, including Michael S. Rosen, William D. Fertig, Charles E. Carnegie, and Context Partners Master Fund, L.P., collectively...

On June 9, 2026, Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen filed a Schedule 13G regarding their holdings in Design Therapeutics, Inc. (DSGN). The filing reports that as of June 8, 2026, the reporting persons collectively beneficially own 3,197,764 shares of common stock, repres...

On June 9, 2026, Jane Street Group, LLC, along with its subsidiaries Jane Street Capital, LLC and Jane Street Global Trading, LLC, filed a Schedule 13G regarding their holdings in GeoVax Labs, Inc. (GOVX). The filing indicates that as of the event date on June 3, 2026, the reporting persons collectively acquired 292,83...

On June 9, 2026, Context Capital Management, LLC, along with affiliated entities and individuals, filed a Schedule 13G disclosing a new 9.9% stake in Gossamer Bio, Inc. (GOSS). The reporting persons, including Michael S. Rosen, William D. Fertig, Charles E. Carnegie, and Context Partners Master Fund, L.P., collectively...